Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Stephen Ansell MD, PhD

Stephen M. Ansell MD, PhD

Consultant, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota

Stephen Ansell, M.D., Ph.D. is a consultant in the Division of Hematology, Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota. He serves as the chair of faculty development and recruitment for the Division of Hematology, and as the chair of the Lymphoma Group in the Division of Hematology. He holds the rank of professor of medicine, Mayo Clinic College of Medicine.

Dr. Ansell earned his MB, ChB degree and completed an internal medicine/surgery internship at University of Pretoria in South Africa. At the same school he completed a residency in internal medicine and a fellowship in medical oncology, and earned his Ph.D. in medical sciences. Dr. Ansell went on to earn a Diploma in Tropical Medicine and Hygiene at University of the Witwatersrand in Johannesburg, South Africa. At Mayo Clinic College of Medicine he completed an internal medicine residency and a hematology/oncology fellowship.

Dr. Ansell’s research interests include: Tumor microenvironment in lymphoma; the role of TNF family molecules in lymphoma; G-protein coupled receptors in lymphoma; and developing novel biological therapies for non-Hodgkin lymphoma. As a member of the Lymphoma Group, he holds specific expertise in T-cell lymphoma and Hodgkin lymphoma, and is also an expert in transplantation of lymphoma within with the Bone Marrow Transplant Group.

Dr. Ansell has been invited to present on his work internationally and maintains highly productive academic output. His research has resulted in two United States patents and achieved publication in numerous high-impact scientific journals. He has garnered competitive funding from several industry, federal, and foundation granting sources, including the National Institutes of Health, the Leukemia & Lymphoma Society, the International Waldenstrom’s Macroglobulinemia Foundation and the Lymphoma Research Foundation of America, Inc.

Dr. Ansell serves as an associate editor for American Journal of Hematology and for Blood Cancer Journal, and is a past editorial board member for Journal of Clinical Oncology. Throughout his training and career he has been the recipient of many honors and awards, including: the Lennon Oncology Medal for Young Investigators, the Mayo Brothers' Distinguished Fellowship Award, and the Mayo Clinic New Investigator Award. 

Recent Contributions to PracticeUpdate:

  1. Targeting PD-L1 and PD-L2 Signaling Across the Spectrum of Classical Hodgkin’s
  2. Classical Hodgkin's Lymphoma Defined by Alterations of PD-L1/PD-L2
  3. Efficacy of Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma